Open access
122
Views
0
CrossRef citations to date
0
Altmetric
Review
Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
Joanna Waclaw1 Department of Hematology, Jagiellonian University Collegium Medicum, Kraków
, Tomasz Sacha1 Department of Hematology, Jagiellonian University Collegium Medicum, Kraków
& Tomasz Stoklosa2 Department of Immunology, Medical University of Warsaw, Warsaw, PolandCorrespondence[email protected]
Pages 101-108
|
Published online: 09 Sep 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.